Raymond James & Associates’s Mellanox Technologies, Ltd. MLNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-35,360
Closed -$4.29M 3730
2020
Q1
$4.29M Buy
35,360
+4,008
+13% +$471K 0.01% 1128
2019
Q4
$3.67M Sell
31,352
-3,861
-11% -$439K ﹤0.01% 1451
2019
Q3
$3.86M Buy
35,213
+780
+2% +$86.1K 0.01% 1371
2019
Q2
$3.81M Sell
34,433
-2,050
-6% -$236K 0.01% 1384
2019
Q1
$4.32M Sell
36,483
-513
-1% -$51.6K 0.01% 1266
2018
Q4
$3.42M Sell
36,996
-4,828
-12% -$410K 0.01% 1305
2018
Q3
$3.07M Sell
41,824
-7,960
-16% -$640K ﹤0.01% 1536
2018
Q2
$4.2M Buy
49,784
+18,016
+57% +$1.48M 0.01% 1304
2018
Q1
$2.31M Sell
31,768
-3,450
-10% -$232K ﹤0.01% 1616
2017
Q4
$2.28M Sell
35,218
-8,775
-20% -$464K ﹤0.01% 1610
2017
Q3
$2.07M Sell
43,993
-6,167
-12% -$280K ﹤0.01% 1620
2017
Q2
$2.17M Buy
50,160
+29,838
+147% +$1.42M ﹤0.01% 1525
2017
Q1
$1.03M Buy
+20,322
New +$965K ﹤0.01% 1962
2016
Q2
Sell
-12,746
Closed -$692K 3118
2016
Q1
$692K Buy
+12,746
New +$591K ﹤0.01% 1869

Other funds holding MLNX

Raymond James & Associates's MLNX Position: Q2 2020 in Review

Raymond James & Associates sold out of Mellanox Technologies, Ltd. (MLNX) in Q2 2020, closing a stake of 35,360 shares — an estimated $4.29M sold.

Raymond James & Associates first reported a position in MLNX in Q1 2016 and held it in 14 quarters. The position peaked at $4.32M in Q1 2019. 22 funds tracked by Wall St. Rank hold MLNX as of Q2 2020.

  • Raymond James & Associates reported no remaining Mellanox Technologies, Ltd. position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 35,360 Mellanox Technologies, Ltd. shares in Q2 2020, an estimated $4.29M.
  • Raymond James & Associates first reported a position in Mellanox Technologies, Ltd. in Q1 2016 and held it in 14 quarters.
  • Raymond James & Associates's Mellanox Technologies, Ltd. position peaked at $4.32M in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Mellanox Technologies, Ltd. as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.